In vivo and in vitro evidence for epidermal H2O2-mediated oxidative stress in piebaldism

Experimental Dermatology

Volumn 19, Issue 10, 2010, Pages 883-887

  Vafaee, Tayyebeh ^a,b   Rokos, Hartmut ^a,b   Salem, Mohamed M A E L ^a,b   Schallreuter, Karin U ^a,b  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

6 tetrahydrobiopterin; Catalase; H2O2; Methionine sulphoxide reductases A B; Superoxide dismutases 1,2,3; Thioredoxin reductase

Indexed keywords

CATALASE; DRUG DERIVATIVE; HYDROGEN PEROXIDE; METHIONINE; METHIONINE SULFOXIDE; METHIONINE SULFOXIDE REDUCTASE; MSRB2 PROTEIN, HUMAN; PTERIDINE DERIVATIVE; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR;

ADULT; ARTICLE; BIOPSY; CASE REPORT; EPIDERMIS; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; IN VITRO STUDY; MALE; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; PHYSIOLOGY; PIEBALDISM; RAMAN SPECTROMETRY; VITILIGO;

ADULT; BIOPSY; CATALASE; EPIDERMIS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; HYDROGEN PEROXIDE; MALE; METHIONINE; METHIONINE SULFOXIDE REDUCTASES; OXIDATIVE STRESS; PIEBALDISM; PTERIDINES; SPECTRUM ANALYSIS, RAMAN; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTORS; VITILIGO;

EID: 79952111707     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2009.00966.x     Document Type: Article

References (35)

1. Cooke M S, Evans M D, Dizdaroglu M, Lunec J. Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J 2003: 17: 1195-1214.
2. Funderburk S J, Crandall B F. Dominant piebald trait in a retarded child with a reciprocal translocation and small intercalary deletion. Am J Hum Genet 1974: 26: 715-722.
3. Telfer M A, Sugar M, Jaeger E A, Mulcahy J. Dominant piebald trait (white forelock and leukoderma) with neurological impairment. Am J Hum Genet 1971: 23: 383-389.
4. Froggatt P. An outline, with bibliography, of human piebaldism and white forelock. Ir J Med Sci 1959: 172: 86-94.
5. Spritz R A. Molecular basis of human piebaldism. J Invest Dermatol 1994: 103: 137S-140S.
6. Smith N G, Schulz J. Partial albinism. AMA Arch Derm 1955: 71: 468-470.
7. Fitzpatrick T B, Lerner A B, Grupper C. [Tyrosinase in normal and diseased pigment cells of the skin; detection by histochemical and biochemical method.]. Bull Soc Fr Dermatol Syphiligr 1954: 61: 33-35.
8. Campbell B, Swift S. Partial albinism. Nine cases in six generations. JAMA 1962: 181: 1103-1106.
9. Comings D E, Odland G F. Partial albinism. JAMA 1966: 195: 519-523.
10. Syrris P, Heathcote K, Carrozzo R et al. Human piebaldism: six novel mutations of the proto-oncogene KIT. Hum Mutat 2002: 20: 234.
11. Jimbow K, Fitzpatrick T B, Szabo G, Hori Y. Congenital circumscribed hypomelanosis: a characterization based on electron microscopic study of tuberous sclerosis, nevus depigmentosus, and piebaldism. J Invest Dermatol 1975: 64: 50-62.
12. Breathnach A S, Fitzpatrick T B, Wyllie L M. Electron Microscopy of Melanocytes in Human Piebaldism. J Invest Dermatol 1965: 45: 28-37.
13. Mayer T C. A comparison of pigment cell development in albino, steel, and dominant-spotting mutant mouse embryos. Dev Biol 1970: 23: 297-309.
14. Ortonne J P. Piebaldism, Waardenburg's syndrome, and related disorders. "Neural crest depigmentation syndromes"?. Dermatol Clin 1988: 6: 205-216.
15. Ezoe K, Holmes S A, Ho L et al. Novel mutations and deletions of the KIT (steel factor receptor) gene in human piebaldism. Am J Hum Genet 1995: 56: 58-66.
16. Schallreuter K U, Wood J M, Pittelkow M R et al. Regulation of melanin biosynthesis in the human epidermis by tetrahydrobiopterin. Science 1994: 263: 1444-1446.
17. Fitzpatrick T B, Breathnach A S. [The Epidermal Melanin Unit System.]. Dermatol Wochenschr 1963: 147: 481-489.
18. Schallreuter K U, Bahadoran P, Picardo M et al. Vitiligo pathogenesis: autoimmune disease, genetic defect, excessive reactive oxygen species, calcium imbalance, or what else? Exp Dermatol 2008: 17: 139-140.
19. 2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase. J Investig Dermatol Symp Proc 1999: 4: 91-96.
20. Rokos H, Wood J M, Hasse S, Schallreuter K U. Identification of epidermal l-tryptophan and its oxidation products by in vivo FT-Raman Spectroscopy further supports oxidative stress in patients with vitiligo. J Raman Spectrosc 2008: 39: 1214-1218.
21. Shalbaf M, Gibbons N C, Wood J M et al. Presence of epidermal allantoin further supports oxidative stress in vitiligo. Exp Dermatol 2008: 17: 761-770.
22. Aronoff S. Catalase: kinetics of photooxidation. Science 1965: 150: 72-73.
23. Maresca V, Flori E, Briganti S et al. UVA-induced modification of catalase charge properties in the epidermis is correlated with the skin phototype. J Invest Dermatol 2006: 126: 182-190.
24. Wood J M, Schallreuter K U. UVA-irradiated pheomelanin alters the structure of catalase and decreases its activity in human skin. J Invest Dermatol 2006: 126: 13-14.
25. 2): potential and pitfalls. J Invest Dermatol 2006: 126: 2576-2582.
26. Schallreuter K U, Hordinsky M K, Wood J M. Thioredoxin reductase. Role in free radical reduction in different hypopigmentation disorders. Arch Dermatol 1987: 123: 615-9.
27. Schallreuter K U, Rokos H, Chavan B et al. Quinones are reduced by 6-tetrahydrobiopterin in human keratinocytes, melanocytes, and melanoma cells. Free Radic Biol Med 2008: 44: 538-546.
28. Casp C B, She J X, McCormack W T. Genetic association of the catalase gene (CAT) with vitiligo susceptibility. Pigment Cell Res 2002: 15: 62-66.
29. Gavalas N G, Akhtar S, Gawkrodger D J, Watson P F, Weetman A P, Kemp E H. Analysis of allelic variants in the catalase gene in patients with the skin depigmenting disorder vitiligo. Biochem Biophys Res Commun 2006: 345: 1586-1591.
30. Park H H, Ha E, Uhm Y K et al. Association study between catalase gene polymorphisms and the susceptibility to vitiligo in Korean population. Exp Dermatol 2006: 15: 377-380.
31. 2) in the epidermis of patients with vitiligo. J Invest Dermatol 2008: 128: 808-815.
32. Spritz R A. The genetics of generalized vitiligo and associated autoimmune diseases. J Dermatol Sci 2006: 41: 3-10.
33. Wood J M, Gibbons N C, Chavan B, Schallreuter K U. Computer simulation of heterogeneous single nucleotide polymorphisms in the catalase gene indicates structural changes in the enzyme active site, NADPH-binding and tetramerization domains: a genetic predisposition for an altered catalase in patients with vitiligo? Exp Dermatol 2008: 17: 366-371.
34. 2-mediated oxidation and nitration enhances DNA binding capacity/DNA repair via upregulated epidermal wild-type p53 in vitiligo. PhD Thesis. Bradford: Department of Biomedical Sciences, University of Bradford, 2009.
35. Rokos H. Radioimmunoassay for determination of biopterin. Pteridines 1989: 1: 224-225.